論文・技術情報追加のお知らせ

①Adverse Drug Reactions Relevant to Drug Resistance and Ineffectiveness Associated with Meropenem, Linezolid, and Colistin: An Analysis Based on Spontaneous Reports from the European Pharmacovigilance Database.

メロペネム、リネゾリド、コリスチンにおける薬剤耐性、無効性に関連する副作用評価研究

対象DB：EudraVigilance

②Cardiac safety profile of type II kinase inhibitors: Analysis of post-marketing reports from databases of European Medicine Agency & World Health Organization.

II型キナーゼ阻害剤における心疾患リスク評価研究

対象DB：EudraVigilance

③Oral side effects of COVID-19 vaccines in 32 European countries: Analysis of EudraVigilance reports.

COVID-19ワクチン接種における口腔内に関連する副作用調査研究

対象DB：EudraVigilance

④Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias?

免疫チェックポイント阻害薬における心筋梗塞リスク調査研究

対象DB：EudraVigilance

⑤Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase((R))).

薬剤耐性結核治療薬における副作用調査研究

対象DB：VigiBase

⑥Evaluation of the Safety Profile of Direct-Acting Antivirals on Patients with Hepatitis C Virus: A Pharmacovigilance Study.

経口直接作用型抗ウイルス薬の有害事象評価研究

対象DB：VigiBase

⑦Impact of Administering Intravenous Azithromycin within 7 Days of Hospitalization for Influenza Virus Pneumonia: A Propensity Score Analysis Using a Nationwide Administrative Database.

インフルエンザウイルス肺炎患者における、アジスロマイシン静脈内投与の効果調査研究

対象DB：DPC